Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Aslan Pharma Completes Auction Phase of $30 Million Taiwan IPO

publication date: May 16, 2017
Aslan Pharma of Singapore completed the competitive auction part of its Taiwan IPO, selling 10.4 million shares at a weighted average bid of NT$68.92 ($2.29). The company will now start a five-day public subscription offering of 2.6 million additional shares at the average price, indicating Aslan's IPO will raise $30 million. Aslan has also announced that, in conjunction with the IPO, it has opened a new office in Taiwan that will support its growing business in Taiwan and Asia. The company's shares will begin trading on the Taipei Exchange on the first day of June. More details....

Stock Symbol: (TT: 6497)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here